Suchergebnisse - "Maartens, Gary"

PubPharm (35)

1

Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB) : a phase 2, non-comparative, randomised controlled trial

enthalten in: The lancet. HIV | 2023

von Griesel, R. | Zhao, Y. | Simmons, B. | +6

CommentIn: Lancet HIV. 2023 Jul;10(7):e422-e423. - PMID 37230100

2

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis : The LASER-TBM Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Davis, A. | Wasserman, S. | Stek, C. | +29

3

Drug-drug interaction between rifabutin and dolutegravir : A population pharmacokinetic model

enthalten in: British journal of clinical pharmacology | 2023

von Kawuma, A. | Wasmann, R. | Dooley, K. | +2

CommentIn: Br J Clin Pharmacol. 2023 Jul;89(7):2329-2331. - PMID 37077127

4

The impact of enteral feeding and therapeutic monitoring of rifampicin with dose escalation in critically ill patients with tuberculosis

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Perumal, R. | Naidoo, K. | Naidoo, A. | +8

5

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT) : a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial

enthalten in: Trials | 2022

von Van Rie, A. | De Vos, E. | Costa, E. | +24

6

Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin-resistant tuberculosis

enthalten in: British journal of clinical pharmacology | 2022

von Court, R. | Gausi, K. | Mkhize, B. | +6

7

Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa : a retrospective cohort study

enthalten in: The Lancet. Infectious diseases | 2022

von Ndjeka, N. | Campbell, J. | Meintjes, G. | +12

CommentIn: Lancet Infect Dis. 2022 Jul;22(7):923-924. - PMID 35512717

8

The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells : a Dose Escalation Study

enthalten in: Antimicrobial agents and chemotherapy | 2022

von De Nicolò, A. | Calcagno, A. | Motta, I. | +8

9

Population Pharmacokinetic Model and Alternative Dosing Regimens for Dolutegravir Coadministered with Rifampicin

enthalten in: Antimicrobial agents and chemotherapy | 2022

von Kawuma, A. | Wasmann, R. | Dooley, K. | +3

10

An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis : A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)

enthalten in: American journal of respiratory and critical care medicine | 2022

von Esmail, A. | Oelofse, S. | Lombard, C. | +21

CommentIn: Am J Respir Crit Care Med. 2022 May 15;205(10):1142-1144. - PMID 35320062